HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roland Jimenez Selected Research

valbenazine

1/2021A long-term, open-label study of valbenazine for tardive dyskinesia.
11/2019A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia.
1/2018Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials.
11/2017The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study.
1/2017KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
1/2017Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects.
10/2015NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roland Jimenez Research Topics

Disease

7Tardive Dyskinesia
01/2021 - 10/2015
4Endometriosis
11/2014 - 02/2009
3Dysmenorrhea (Menstrual Pain)
11/2014 - 07/2013
3Pain (Aches)
11/2014 - 07/2013
3Pelvic Pain
11/2014 - 07/2013
2Dyskinesias (Dyskinesia)
11/2019 - 10/2015
2Psychotic Disorders (Schizoaffective Disorder)
11/2017 - 01/2017
2Mood Disorders (Mood Disorder)
11/2017 - 01/2017
2Schizophrenia (Dementia Praecox)
11/2017 - 01/2017
2Movement Disorders (Movement Disorder)
01/2017 - 10/2015
2Headache (Headaches)
11/2014 - 07/2013
2Nausea
11/2014 - 07/2013
1Mental Disorders (Mental Disorder)
01/2018
1Psychomotor Agitation (Akathisia)
11/2017
1Parkinsonian Disorders (Parkinsonism)
11/2017
1Nasopharyngitis
11/2014
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2014
1Dyspareunia
07/2013
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2009
1Leiomyoma (Uterine Fibroids)
02/2009

Drug/Important Bio-Agent (IBA)

7valbenazineIBA
01/2021 - 10/2015
4Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
01/2018 - 01/2017
3elagolixIBA
11/2014 - 07/2013
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2014 - 02/2009
2Antipsychotic Agents (Antipsychotics)IBA
01/2017 - 10/2015
2Peptides (Polypeptides)IBA
11/2009 - 02/2009
1Dopamine (Intropin)FDA LinkGeneric
01/2018
1Dopamine Receptors (Dopamine Receptor)IBA
01/2017
1Pharmaceutical PreparationsIBA
10/2015
1N,N-dimethyl-4-anisidine (DMPA)IBA
11/2014
1Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
11/2014
1NBI6024IBA
11/2009
1Insulin (Novolin)FDA Link
11/2009
1LigandsIBA
11/2009

Therapy/Procedure

1Subcutaneous Injections
11/2009
1Therapeutics
02/2009